We are live on
!
Find out more
Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$39.1B
1-Year Est. Return
28.69%
This Fund
S&P 500
This Quarter
Est. Return
+11.33%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.4%
AUM
$33.2B
AUM Growth
+$1.51B
(+4.8%)
Cap. Flow
-$765M
Cap. Flow
% of AUM
-2.3%
Top 10 Holdings %
Top 10 Hldgs %
38.35%
Holding
705
New
90
Increased
190
Reduced
272
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$287M |
| 2 |
Tradeweb Markets
TW
|
+$207M |
| 3 |
Constellation Brands
STZ
|
+$187M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$165M |
| 5 |
Meta Platforms (Facebook)
META
|
+$99.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$526M |
| 2 |
Visa
V
|
+$191M |
| 3 |
Apple
AAPL
|
+$144M |
| 4 |
Oracle
ORCL
|
+$57.6M |
| 5 |
Elevance Health
ELV
|
+$47.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.78% |
| 2 | Healthcare | 21.92% |
| 3 | Financials | 11.41% |
| 4 | Communication Services | 10.63% |
| 5 | Consumer Discretionary | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Teva Pharmaceuticals
TEVA
$42.1B
| $257K | ﹤0.01% |
+15,337
| New | +$247K |
|
577
Equitable Holdings
EQH
$14.4B
| $253K | ﹤0.01% |
+4,505
| New | +$232K |
|
578
Jacobs Solutions
J
$17.2B
| $250K | ﹤0.01% |
+1,900
| New | +$234K |
|
579
Hanmi Financial
HAFC
$939M
| $245K | ﹤0.01% |
9,928
-1,033
| -9% | -$23.6K |
|
580
Jazz Pharmaceuticals
JAZZ
$16.7B
| $241K | ﹤0.01% |
2,267
-5,854
| -72% | -$636K |
|
581
First Bancorp
FBP
$4.42B
| $236K | ﹤0.01% |
11,347
| – | – |
|
582
CenterPoint Energy
CNP
$26.4B
| $235K | ﹤0.01% |
+6,407
| New | +$237K |
|
583
Primoris Services
PRIM
$4.35B
| $235K | ﹤0.01% |
+3,009
| New | +$204K |
|
584
Turning Point Brands
TPB
$1.79B
| $233K | ﹤0.01% |
+3,075
| New | +$209K |
|
585
Host Hotels & Resorts
HST
$15.5B
| $229K | ﹤0.01% |
14,936
-33,434
| -69% | -$495K |
|
586
ArcBest
ARCB
$3.07B
| $229K | ﹤0.01% |
+2,978
| New | +$194K |
|
587
Telkom Indonesia
TLK
$14.7B
| $228K | ﹤0.01% |
13,478
-887
| -6% | -$14.2K |
|
588
Sally Beauty Holdings
SBH
$1.57B
| $224K | ﹤0.01% |
24,234
| – | – |
|
589
Dana Inc
DAN
$3.21B
| $224K | ﹤0.01% |
13,073
| – | – |
|
590
Interface
TILE
$2.18B
| $221K | ﹤0.01% |
10,551
| – | – |
|
591
Virtu Financial
VIRT
$4.92B
| $220K | ﹤0.01% |
4,905
-14,087
| -74% | -$568K |
|
592
Spok Holdings
SPOK
$237M
| $218K | ﹤0.01% |
12,307
| – | – |
|
593
World Kinect Corp
WKC
$1.89B
| $210K | ﹤0.01% |
7,416
-1,242
| -14% | -$32.9K |
|
594
Capital City Bank Group
CCBG
$881M
| $209K | ﹤0.01% |
+5,300
| New | +$195K |
|
|
PDM
595
Piedmont Realty Trust
PDM
$1.16B
| $200K | ﹤0.01% |
27,400
| – | – |
|
596
MasterBrand
MBC
$1.84B
| $196K | ﹤0.01% |
17,938
| – | – |
|
597
PUT
Rocket Companies
RKT
$39B
| $189K | ﹤0.01% |
+13,300
| New | +$173K |
|
598
MDU Resources
MDU
$4.29B
| $187K | ﹤0.01% |
+11,197
| New | +$188K |
|
599
Nokia
NOK
$51B
| $162K | ﹤0.01% |
31,257
-3,854
| -11% | -$19.9K |
|
600
NatWest
NWG
$76.3B
| $147K | ﹤0.01% |
10,388
| – | – |
|
Similar funds
HF
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2025 Portfolio in Review
As of Q2 2025, Grantham, Mayo, Van Otterloo & Co (GMO) held 705 positions worth $33.2B, up 4.8% from $31.7B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2025 filing shows 90 new, 190 increased, 272 reduced and 97 closed positions. Its largest new stake was Tradeweb Markets: 1,483,629 shares worth $217M. The largest sale was Otis Worldwide, an estimated $526M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2025 buy was Tradeweb Markets: 1,483,629 shares worth $217M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Broadcom in Q2 2025, an estimated $287M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2025 reduction was Otis Worldwide, cutting an estimated $526M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Saia in Q2 2025, selling an estimated $41.2M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 38% of its $33.2B portfolio in Q2 2025.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 90 new positions and closed 97 in Q2 2025.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 4.8% quarter-over-quarter to $33.2B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2025, filed 13 Aug 2025.